Parkinson's disease and genetics

Neurologist

Volumn 12, Issue 5, 2006, Pages 240-244

  Lester, Jacobo ^b,c   Otero Siliceo, Enrique ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Hospital de Clínicas José de San Martín   (Mexico)

^c AMERICAN BRITISH COWDRAY MEDICAL CENTER   (Mexico)

Author keywords

Disease; Genetics; Parkinson

Indexed keywords

ARTICLE; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; HEREDITY; HUMAN; IDIOPATHIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; TWINS;

HUMANS; INHERITANCE PATTERNS; MUTATION; PARKINSON DISEASE;

EID: 33748966321     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000237141.29970.e3     Document Type: Article

References (66)

1. Marsden CD. Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994;57:672-681.
2. Lang AE, Lozano AM. Parkinson's disease: first of two parts. N Engl J Med. 1998;339:1044-1053.
3. Rajput AH, Offord KP, Beard CM, et al. Epidemiology of Parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984;16:278-282.
4. Bennet DA, Beckett LOA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334:71-76.
5. Twelves D, Perkins KSM, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord. 2003;18:19-31.
6. Bandmann O, Marsden D, Wood NW. Genetic aspects of Parkinson's disease. Mov Disord. 1998;13:203-211.
7. Marsden CD, Olanow CW. The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality. Ann Neurol. 1998;44(suppl 1):S189-S196.
8. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology. 1997;48:650-658.
9. Anderson C, Checkoway H, Franklin GM, et al. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord. 1999;14:21-27.
10. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology. 1998;51(suppl 2):S2-S9.
11. Chase TN, Justine D, Blanchet PJ. Neostratial mechanism in Parkinson's disease. Neurology. 1998;51(suppl 2):S30-S35.
12. Spacey SD, Wood NW. The genetics of Parkinson's disease. Curr Opin Neurol. 1999;12:427-432.
13. Gasser T. Genetics of Parkinson's disease. Curr Opin Neurol. 2005;18:363-369.
14. Siderowf A, Stern M. Update on Parkinson's disease. Ann Intern Med. 2003;138:651-658.
15. Tanner CM, Ottman R, Goldman SM, et al. Parkinson's disease in twins: an etiologic study. JAMA. 1999;281:341-346.
16. Sveinbjörnsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med. 2000;343:1765-1770.
17. Kitada T, Asakawa S, Hattori N, et al. Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism. Nature. 1998;392:605-608.
18. Lücking CB, Dürr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the Parkin gene: French Parkinson's Disease Genetics Study Group. N Engl J Med. 2000;342:1560-1567.
19. Mjones H. Paralysis agitans: a clinical and genetic study. Acta Psychiat Neurol Scand. 1949;54(suppl):1-195.
20. Dekker MCJ, Bonifati V, van Duijn CM. Parkinson's disease: piecing together a genetic jigsaw. Brain. 2003;126:1722-1733.
21. Golbe LI, Di Iorio G, Bonavita V, et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol. 1990;27:276-282.
22. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.
23. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene coding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18:106-108.
24. Papapetropoulos S, Paschalis C, Athanassiadou A, et al. Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70:662-665.
25. Spira PJ, Sharpe DM, Halliday G, et al. Clinical and pathological features of Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol. 2001;49:313-319.
26. Duda JE, Giasson BI, Mabon ME, et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol. 2002;104:7-11.
27. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988;8:2804-2815.
28. George JM, Jin H, Woods WS, et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 1995;15:361-372.
29. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4:1318-1320.
30. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:153-156.
31. Ishikawa A, Takahashi H. Clinical and neuropathological aspects of autosomal recessive juvenile Parkinsonism. J Neurol. 1998;245(11 suppl 3):P4-P9.
32. Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, Parkin, is a ubiquitin-protein ligase. Nat Genet. 2000;25:302-305.
33. Schlossmacher MG, Frosch MP, Gai WP, et al. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol. 2002;160:1655-1667.
34. Shimura H, Schlossmacher MG, Hattori N, et al. Ubiquitination of a new form of alpha-synuclein by Parkin from human brain: implications for Parkinson's disease. Science. 2001;293:263-269.
35. Koening M, Hoffman EP, Bertelson CJ, et al. Complete cloning of the Duschenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50:509-517.
36. Kann M, Jacobs H, Mohrmann K, et al. Role of Parkin mutations in 111 community based patients with early-onset Parkinsonism. Ann Neurol. 2002;51:621-625.
37. Khan NL, Brooks DJ, Pavese N, et al. Progression of nigrostratial dysfunction in a Parkin kindred: a (18F) dopa PET and clinical study. Brain. 2002;125:2248-2256.
38. Gasser T. Genetics of Parkinson's disease. J Neurol. 2001;248:833-840.
39. Wszolek ZK, Gwinn-Hardy K, Wszolek EK, et al. Neuropathology of two members of a German-American kindred (Family C) with late onset Parkinsonism. Acta Neuropathol (Berl). 2002;103:344-350.
40. Farrer M, Gwinn-Hardy K, Muenter M, et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet. 1999;8:81-85.
41. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841-844.
42. Spellman GG. Report of familial cases of Parkinsonism. JAMA. 1962;179:372-374.
43. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol. 1994;35:59-64.
44. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of Parkinsonism dementia. Ann Neurol. 1998;43:768-781.
45. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature. 1998;395:451-452.
46. Saigoh K, Wang YL, Suh JG, et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in the in GAD mice. Nat Genet. 1999;23:47-51.
47. Valente EM, Bentivoglio AR, Dixon PH, et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, Park 6, on human chromosome 1p35-p36. Am J Hum Genet. 2001;68:895-900.
48. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304:1158-1160.
49. Valente EM, Brancati F, Ferraris A, et al. Park 6-linked parkinsonism occurs in several European families. Ann Neurol. 2002;51:14-18.
50. van Duijn CM, Dekker MC, Bonifati V, et al. Park 7, a novel locus for autosomal recessive early-onset Parkinsonism, on chromosome 1p36. Am J Hum Genet. 2001;69:629-634.
51. Healy DG, Abou-Sleiman PM, Valente EM, et al. DJ-1 mutations in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:144-145.
52. Bonifati V, Breedveld GJ, Squitieri F, et al. Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (Park7) in an independent dataset. Ann Neurol. 2002;51:253-256.
53. Dekker M, Bonifati V, van Swieten JC, et al. Clinical features and neuroimaging of Park7-linked parkinsonism. Mov Disord. 2003;18:751-757.
54. Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson's disease (Park8) maps to chromosome 12p11.2-q13.1. Ann Neurol. 2002;51:296-301.
55. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 2004;44:595-600.
56. Cookson MR, Xiromerisiou G, Singleton A. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease. Curr Opin Neurol. 2005;18:706-711.
57. Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2006;354:424-425.
58. Lasagne S, Dürr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med. 2006;354:422-423.
59. Brice A. Genetics of Parkinson's disease: LRRK2 on the rise. Brain. 2005;128:2760-2762.
60. Hampshire DJ, Roberts E, Crow Y, et al. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet. 2001;38:680-682.
61. Najim al-Din AS, Wriekat A, Mubaidin A, et al. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand. 1994;89:347-352.
62. Williams DR, Hadeed A, al-Din AS, et al. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord. 2005;20:1264-1271.
63. Hicks AA, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol. 2002;52:549-555.
64. Le WD, Xu P, Jankovic J, et al. Mutations in NR4A2 associated with familial Parkinson's disease. Nat Genet. 2003;33:85-89.
65. Zetterstrom RH, Williams R, Perlmann T, et al. Cellular expression of the immediate early transcription factors NURR1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigro-striatal dopamine system. Brain Res Mol Brain Res. 1996;41:111-120.
66. Le W, Conneely OM, Zou L, He Y, et al. Selective agenesis of mesencephalic dopaminergic neurons in NURR-1 deficient mice. Exp Neurol. 1999;159:451-458.